The efficacy of erythropoietin in human immunodeficiency virus-infected end-stage renal disease patients treated by maintenance hemodialysis.

@article{Shrivastava1995TheEO,
  title={The efficacy of erythropoietin in human immunodeficiency virus-infected end-stage renal disease patients treated by maintenance hemodialysis.},
  author={Dr Nisha Shrivastava and T K Sreepada Rao and Richard H. Sinert and Ekta Khurana and Anne Lundin and Eli A. Friedman},
  journal={American journal of kidney diseases : the official journal of the National Kidney Foundation},
  year={1995},
  volume={25 6},
  pages={904-9}
}
The superimposition of human immunodeficiency virus (HIV) infection, associated opportunistic infections, and anti-retroviral therapy further worsens the severity of anemia in patients also suffering from end-stage renal disease. A major cause of anemia in renal failure is a deficiency of erythropoietin. The causes of anemia in HIV disease include direct and indirect stem cell inhibition by the virus, increased peripheral destruction of red blood cells, and bone marrow suppression by various… CONTINUE READING